{"id":315445,"date":"2026-10-19T10:07:08","date_gmt":"2026-10-19T04:37:08","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=315445"},"modified":"2026-10-19T10:07:08","modified_gmt":"2026-10-19T04:37:08","slug":"paras-healthcare-initial-public-offering-review","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/paras-healthcare-initial-public-offering-review\/","title":{"rendered":"Paras Healthcare IPO Review: Key Details, Company Overview and Financials"},"content":{"rendered":"

Paras Healthcare IPO price band Rs 660 to Rs 693. Opens 21 Oct, closes 23 Oct 2026. Issue size about Rs 1,450 Cr. Lists 28 Oct on BSE and NSE.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Paras Healthcare IPO is a Rs 1,450 crore issue (about Rs 500 crore fresh plus Rs 950 crore offer for sale) priced at Rs 660 to Rs 693 per share, open from 21 to 23 October 2026 on BSE and NSE. The company runs eight hospitals with 2,211 beds under the Paras Health brand, and Rs 375 crore of the fresh issue is meant to repay debt. FY26 profit after tax was Rs 43.83 crore after a loss of Rs 57.98 crore in FY25, and debt to equity is 3.53, so the pricing leans heavily on the recovery continuing.<\/p>\n<\/p><\/div>\n

The Paras Healthcare IPO is a bookbuilding issue of about Rs 1,450 crore, made up of a fresh issue of 72,15,007 equity shares aggregating about Rs 500 crore and an offer for sale of 1,37,08,513 shares aggregating about Rs 950 crore by promoter Dharminder Kumar Nagar (Rs 300 crore) and investor Commelina Ltd. (Rs 650 crore). The issue was earlier planned at Rs 1,800 crore. Face value is Re 1 per share. Anchor bidding is on 19 October, and the issue opens on 21 October 2026 and closes on 23 October 2026. Allotment is expected on 26 October, and the shares are proposed to list on BSE and NSE on 28 October 2026.<\/p>\n

The price band is Rs 660 to Rs 693 per share with a lot size of 21 shares, so one lot needs Rs 14,553 at the upper band. Retail investors can bid up to 13 lots (273 shares, Rs 1,89,189), and small HNI bids run from 14 lots (294 shares, Rs 2,03,742) to 68 lots (Rs 9,89,604). Not more than 75 percent of the net offer is for qualified institutional buyers, at least 15 percent for non-institutional investors and at least 10 percent for retail investors.<\/p>\n

JM Financial Ltd., BofA Securities India Ltd. and Nuvama Wealth Management Ltd. are the book-running lead managers for the Paras Healthcare issue, and MUFG Intime India Pvt. Ltd. is the registrar.<\/p>\n

For detailed information on the company’s business, financials, risk factors and the use of proceeds, investors should refer to the Paras Healthcare Red Herring Prospectus (RHP) before making an investment decision.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n